BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang J, Liu MH, Gao X, Dong C, Li YX. Vedolizumab-associated diffuse interstitial lung disease in patients with ulcerative colitis: A case report. World J Clin Cases 2022; 10(5): 1716-1722 [PMID: 35211614 DOI: 10.12998/wjcc.v10.i5.1716]
URL: https://www.wjgnet.com/2307-8960/full/v10/i5/1716.htm
Number Citing Articles
1
Carolina Aliai Micol Cavalli, Roberto Gabbiadini, Arianna Dal Buono, Alessandro Quadarella, Alessandro De Marco, Alessandro Repici, Cristina Bezzio, Edoardo Simonetta, Stefano Aliberti, Alessandro Armuzzi. Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted ConnectionsJournal of Clinical Medicine 2023; 12(19): 6419 doi: 10.3390/jcm12196419
2
Yang Li, Xiao-meng Li, Hao-yu Duan, Kai-di Yang, Jun-feng Ye. Advances and optimization strategies in bacteriophage therapy for treating inflammatory bowel diseaseFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1398652
3
Jing Wang, Lin Luo, Xingtao Zhao, Xinyan Xue, Li Liao, Ying Deng, Mengting Zhou, Cheng Peng, Yunxia Li. Forsythiae Fructuse extracts alleviates LPS-induced acute lung injury in mice by regulating PPAR-γ/RXR-α in lungs and colonsJournal of Ethnopharmacology 2022; 293: 115322 doi: 10.1016/j.jep.2022.115322
4
Multiple drugsReactions Weekly 2022; 1902(1): 305 doi: 10.1007/s40278-022-13449-5